Fact.MR – A Market Research and Competitive Intelligence Provider: According to the latest Fact.MR analysis, the global chemiluminescence immunoassay analyzers market is projected to expand positively at a CAGR of 6.4% and is expected to reach US$ 7.6 Bn in the forecast period of 2020-2025.
The Global Chemiluminescence immunoassay Analyzers Market Is Estimated to Grow at a CAGR Of 6.4 %, Reaching US$ 7.6 Billion by 2025
Fact.MR – A Market Research and Competitive Intelligence Provider: According to the latest Fact.MR analysis, the global chemiluminescence immunoassay analyzers market is projected to expand positively at a CAGR of 6.4% and is expected to reach US$ 7.6 Bn in the forecast period of 2020-2025. The reagents segment is anticipated to capture almost three-fourth of the overall CLIA market, reaching a value of US$ 5.7 Bn by the end of 2025.
Infectious disease, autoimmune disease, cardiovascular disease, diabetes, obesity, and cancer are among the chronic disorders for which chemiluminescence immunoassay analyzers solutions are commonly used. Chemiluminescence immunoassay analyzers is also used for therapeutic medication monitoring by a number of pharmaceutical corporations and research institutes.
The COVID-19 pandemic is anticipated to provide further impetus to the global chemiluminescence immunoassays analyzers market. Several market players and healthcare agencies are investing in developing diagnostic tests based on chemiluminescence immunoassay analyzers technique to ascertain growth inhibition approaches to the novel coronavirus using a range of techniques
Request a report sample to gain comprehensive insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=4734
Analyst’s Viewpoint:
“Key manufacturers are increasingly investing in CLIA-based techniques for providing testing kits to its clients. The COVID-19 pandemic has further heightened prospects for the CLIA market. Development of a peptide-based magnetic chemiluminescence enzyme immunoassay for serological diagnosis is under way to that effect. Overall, the global CLIA market is poised to enjoy a positive growth trajectory.”
High-impact contributing factors for the market include rising awareness about early identification of chronic diseases and increased medication discovery and development activity by pharmaceutical companies.
Rise in demand for faster and specific diagnosis to support rapid decision-making is boosting the demand for multiplexed and automated chemiluminescence immunoassay analyzers. Anticipated CAGR for the North American chemiluminescence immunoassay analysers market is pegged at 6.1%, capturing a market share of nearly two-fifth.
The global CLIA market is highly consolidated, dominated by four key market players.
- F. Hoffmann La Roche Ltd.,
- Abbott Laboratories,
- Siemens Healthineers and
- Beckman Coulter, Inc. E
Request Chemiluminescence Immunoassays (CLIA) Market Customization at https://www.factmr.com/connectus/sample?flag=RC&rep_id=4734
Global Chemiluminescence Immunoassays (CLIA) Market Segmentation
Fact.MR has studied the global chemiluminescence immunoassays (CLIA) market with detailed segmentation on the basis of application, product, end-user and key regions.
Application
- Endocrine Disorders
- Oncology
- Infectious Diseases
- Hepatitis and Retrovirus
- Cardiovascular Disorders
- Allergy
- Autoimmunity
- Drug Discovery & Development
- Others
Product
Analyzers:
- Fully-automated
- Semi-automated
- Reagents:
- Luminophore Markers
- Enzymatic Markers
- Consumables
End-User
- Hospitals
- Clinical Laboratories
- Pharmaceutical & Biological Industries
- Others
Key Regions
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
“This taxonomy prepared is confidential and intended exclusively for the individual or entity with whom it is being shared. Reading, disseminating, distributing, or copying this to any party other than the addressee(s) is unauthorized and prohibited.”
Enquire Before Buying Here – https://www.factmr.com/connectus/sample?flag=EB&rep_id=4734
Key Takeaways of Global Chemiluminescence immunoassay analyser market Study:
- Semi-automated analyzers are anticipated to expand healthily at a CAGR of 6.4% during the forecast period. An uptick in the number of market players offering integrated systems and prevalence of multiplexed analyzers are poised to drive the segment’s growth.
- By application, the endocrine disorders segment promises impressive growth opportunities. Major factors responsible for its growth are continuous innovations in test offerings and wide production portfolios of key manufacturers. Projections indicate a market share of almost half and a CAGR of 6.9%.
- By end-use, clinical laboratories are forecast to register relatively high CAGR of 6.6%. This is attributed to rising penetration of private laboratories and growing preference of patients for clinical laboratories. Moreover, expanding base of clinical laboratories and increase in number of test procedures are likely to drive the clinical laboratories segment growth.
- Regionally, North America shall retain its hegemony over the CLIA market, owing to a burgeoning demand for faster and specific diagnosis to aid decision-making amongst end-users. Anticipated market share for the region amounts to nearly two-fifth of the global CLIA market.
- Asia-Pacific shows lucrative growth prospects. This is due to gradual adoption of novel products incorporating CLIA technologies, rising market competition amongst key players and greater accreditations to establish more laboratories. The region is anticipated to capture a quarter of the global CLIA market.
- Leading market players, such as Beckman Coulter and Roche AG, have invested heavily in designing several CLIA techniques. Beckman Coulter is testing the implication of indirect measles immunoglobulin (IgM) and Immunoglobulin G (IgG) serology assays on immune reaction towards the SARS-COV2-Virus. This is anticipated to assist them in finding potential growth inhibiting techniques to contain the COVID-19’s spread.
Fact.MR’s Domain Knowledge in Healthcare
Fact.MR’s healthcare and research professionals guide organizations at each step of their business strategy by helping you understand how contemporary influencers impact transformation in the healthcare sector. Our expertise in recognizing the challenges and trends affecting the global healthcare industry provides valuable insight and support, helping identify critical issues and construct relevant solutions. For more information on our deep domain expertise, click here.
Explore Fact. MR’s Coverage on the Healthcare Domain
Immunoassay Market - The global immunoassays market is set to register impressive growth, expanding at a healthy 6.0% CAGR during the forecast period (2020-2026).
Immunoglobulins Market - Intravenous immunoglobulin administration, capturing more than three-quarters of the market, will expand at a CAGR of 7.0% during the forecast period.
Oligonucleotide Synthesis Market - Increased usage of oligonucleotides has augmented the need for technological developments in synthetic chemistry.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000’s trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Source: Fact.MR